This compound is a pharmaceutical intermediate used in the synthesis of statins. It contains a complex aromatic and heterocyclic structure with multiple functional groups, consistent with its role as a building block in the manufacture of cholesterol-lowering medications.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 93957-52-9
Fluvastatin methyl ester
pharmaceutical intermediate for statin synthesis
(R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
Pharmaceutical intermediate for statin synthesis
3-Pyridin-3-yl-D-alanine--hydrogen chloride (1/2)
pharmaceutical intermediate
3-BROMO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Pharmaceutical intermediate
Ethyl 4-(butylamino)benzoate
Pharmaceutical intermediate
5-Chlorobenzotriazole
peptide coupling reagent intermediate
1,1-Dimethylethyl (6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-5-hydroxy-3-oxo-6-heptenoate
statin HMG-CoA reductase inhibitor
FLUVASTATIN SODIUM
active pharmaceutical ingredient
methyl (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3-hydroxy-5-oxohept-6-enoate
KYRVMHRSMHMKAP-OUKQBFOZSA-N
CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(=O)CC(CC(=O)OC)O)C3=CC=C(C=C3)F